CPL JD final with Keegan pictures

Special Feature • Cytowave
Cytowave – A new medical therapy technology
Reliably reduces recovery times from serious tendon and ligament injuries by 5 months
By Richard Parker, Chief Technical Officer, CytoWave
Cytowave is a patented,
non-invasive treatment based
on tissue specific signals.
While other devices in the
equine market use generic
electromagnetic waveforms,
Cytowave offers a tissue
specific analytic method
based on the biology of
the injury. The tissue signal
is derived based upon the
difference in biomagnetic
signals from normal and
injured tissues. This
proprietary SQUID Therapy
Signal (STS) is amplified and
delivered via a mild magnetic
field. This new technology
has been embraced by many
top veterinarians and is being
used as an adjunct to stem
cell therapy or PRP.
The Basics of CytoWave Technology
Equine tendon and ligament injuries occur frequently in both competitive and companion
animals. Unfortunately, this type of trauma does not lend itself to fast, non-invasive recovery
techniques. Disorders of these tendons often become chronic and are difficult to manage
successfully. In most cases, recovery is prolonged for many months and even years.
It is theorized that the mechanism for accelerating the closure of ligament and tendon lesions
is found in the nature of the electromagnetic signals impressed on the subject. The specific
and complex activity known as the “healing process” is an expression of the local activity of
electromagnetic fields, as their generation is spontaneous and inevitable due to ionic and
charged particle flow.
CytoWave Therapy technology takes
an actual electromagnetic signal
given off by the body at an injury site,
stores and then amplifies that signal
before re-admitting to the subject so
as to accelerate the healing process.
This “jump-start” occurs because
the signal applied to the injury is very
similar to the same signal the horse
produces. That signal, therefore, is
readily accepted on a cellular level
and processed in such a manner as
to accelerate the recovery.
Opposing coils held by a boot apparatus deliver
the CytoWave STSTM signal
Thus, we have a targeted, tissue specific physical therapy which can be used for soft (muscle
and nerve), dense (tendons and ligaments) and hard (bone splinters or hairline fractures) tissue
injuries.
Cytowave derived signals contrasted with the much older PEMF technology.
“We’ve used Cytowave
most effectively for
tendon injuries, some
suspensory branch
injuries, it’s been very
helpful.”
— Dr. Tim Ober,
United States Equestrian Team
Simple older PEMF signals
very common in the industry
Actual physiological waveform
which looks nothing like PEMF
Cytowave signals from actual
measurements accelerating repair
These signals have been reported to operate about four times faster than PEMF systems and
obtain consistent results in the 90% range; instead of the 60% range such as is the case with
other popular technologies. As Cytowave uses tissue-specific signals, it is able to achieve
consistent results unlike other technologies which treat every injury the same. In fact, we very
rarely have a failure to close a serious lesion, reduce deep tissue inflammation, relieve sore
back discomfort or accelerate bone fracture repair.
http://bit.ly/EQS2015Summer
16 | Henry Schein Animal Health ph: (855) HSAH-EQ1 (472-4371) | fx: (888) 329-3861 | www.henryscheinvet.com